AbbVie
ABBV
#32
Rank
โ‚น36.312 T
Marketcap
โ‚น20,553
Share price
-0.68%
Change (1 day)
31.01%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น578.09 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น61.16 Billion. , an increase over its 2024 earnings that were of โ‚น359.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น638.65 B77.53%
2024 โ‚น359.74 B-40.54%
2023 โ‚น605.06 B-53.62%
2022 โ‚น1.304 T3.76%
2021 โ‚น1.257 T282.25%
2020 โ‚น328.96 B-59.67%
2019 โ‚น815.72 B62.13%
2018 โ‚น503.12 B-32.74%
2017 โ‚น748.05 B-1.99%
2016 โ‚น763.25 B18.65%
2015 โ‚น643.30 B180.5%
2014 โ‚น229.34 B-55.57%
2013 โ‚น516.19 B-6.86%
2012 โ‚น554.22 B56.05%
2011 โ‚น355.15 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.025 T 60.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.013 T 371.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น879.71 B 37.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น157.12 B-75.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น948.44 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น929.08 B 45.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.419 T 122.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น969.20 B 51.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น77.33 B-87.89%๐Ÿ‡บ๐Ÿ‡ธ USA